Zhejiang Int'l Group Co.,Ltd. (SZSE: 000411)
Health Care · Pharmaceuticals · CN
CN¥10.02
-3.84% today · -11.2% 1Y
Zhejiang Int'l Group Co.,Ltd. (SZSE: 000411) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $843.76M and employs 3,603 people.
Over the last twelve months the share price has lost 11.2%, trading between 8.62 and 14.36.
Tweenvest scores Zhejiang Int'l Group Co.,Ltd. across four factors: quality 74/100, value 56/100, growth 44/100, dividend 68/100. Its strongest factor is quality.
000411 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $843.76M
- Revenue (TTM)
- $5.04B
- P/E
- 12.17
- EPS
- 0.82
- Dividend yield
- 3.53%
- Beta (5Y)
- 0.22
- 52-week high
- CN¥14.36
- 52-week low
- CN¥8.62
- Avg volume (3M)
- —
- Shares outstanding
- 564.85M
- Employees
- 3,603
- Next earnings
- —
About Zhejiang Int'l Group Co.,Ltd.
Founded in 1950, Zhejiang Int'l Group Co.,Ltd. is an enterprise based in Hangzhou, China, specializing in both the bulk distribution and direct sale of pharmaceutical products and medical instruments.
- ISIN
- CNE0000008D9
- Founded
- 1950
- Listed since
- Jul 16, 1996
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Chongqing Lummy Pharmaceutical Co., Ltd.SZSE: 300006 | $875.23M | CN¥5.56 | +2.02% |
| Sanofi Consumer Healthcare India LimitedNSEI: SANOFICONR | $856.18M | Rs3,600.50 | -3.29% |
| Wuhan Keqian Biology Co.,LtdSHSE: 688526 | $853.44M | CN¥12.34 | +1.31% |
| HK inno.N CorporationKOSDAQ: A195940 | $844.58M | ₩40,150.00 | +3.35% |
| Shandong Wit Dyne Health Co.,Ltd.SZSE: 000915 | $836.89M | CN¥23.95 | +0.50% |
| Guizhou Xinbang Pharmaceutical Co., Ltd.SZSE: 002390 | $836.84M | CN¥2.96 | +1.72% |
| Shouyao Holdings (Beijing) Co., LTD.SHSE: 688197 | $835.85M | CN¥37.70 | -0.05% |
| SpyGlass Pharma, Inc.NasdaqGS: SGP | $833.52M | $24.62 | -1.20% |
Figures last refreshed Oct 4, 2026.